A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Advanced Search

You could also try: resembling (46)

Cisplatin and Gemcitabine

Description
Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) CISPLATIN-GEMCITABINE Regimen NSCLC – Cisplatin-Gemcitabine Indication Non-small cell lung cancer (in
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/CisplatinandGemcitabinever12.pdf

MesoCisPemVer1.3

Description
Chemotherapy Protocol MESOTHELIOMA CISPLATIN-PEMETREXED Regimen Mesothelioma – Cisplatin-Pemetrexed Indication First line therapy of advanced pleural mesothelioma where the disease is
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Mesothelioma/MesoCisPemVer1.3.pdf

Cisplatin-Etoposide (intravenous)

Description
Chemotherapy Protocol LUNG CANCER – SMALL CELL (SCLC) CISPLATIN-ETOPOSIDE (Intravenous) Regimen SCLC – Cisplatin-Etoposide IV Indication Limited stage SCLC Usually given
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-small-cellSCLC/Cisplatin-Etoposideintravenous.pdf

Paclitaxel (7 day)

Description
Chemotherapy Protocol BLADDER CANCER PACLITAXEL (7 day) Regimen • Bladder Cancer – Paclitaxel (7 day) Indication • Treatment of locally advanced or metastatic bladder
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Bladdercancer/Paclitaxel-7-day.pdf

Cisplatin Doxorubicin Methotrexate Vinblastine (accelerated) ver1.1

Description
Chemotherapy Protocol BLADDER CISPLATIN-DOXORUBICIN-METHOTREXATE-VINBLASTINE (Accelerated MVAC) Regimen Bladder-Cisplatin-Doxorubicin-Methotrexate-Vinblastine (AccMVAC) Indication First or second line
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Bladdercancer/Cisplatin-Doxorubicin-Methotrexate-Vinblastine-accelerated-ver1.1.pdf

InP-Bleomycin-Cisplatin-Etoposide (5 day-Mod-BEP) Ver1.2

Description
Chemotherapy Protocol GERM CELL BLEOMYCIN-CISPLATIN-ETOPOSIDE (BEP 5 Day Modified) In-Patient Regimen Regimen Germ Cell – InP-Bleomycin-Cisplatin-Etoposide
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Germcell/InP-Bleomycin-Cisplatin-Etoposide-5-day-Mod-BEP-Ver1.2.pdf

BEP5day

Description
Chemotherapy Protocol GERM CELL BLEOMYCIN-CISPLATIN-ETOPOSIDE (BEP 5 Day) Regimen • Germ Cell – Bleomycin-Cisplatin-Etoposide (5 day BEP) Indication • In
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Germcell/BEP5day.pdf

BEP5dayMod

Description
Chemotherapy Protocol GERM CELL BLEOMYCIN-CISPLATIN-ETOPOSIDE (BEP 5 Day Modified) Regimen • Germ Cell – Bleomycin-Cisplatin-Etoposide (5 day-Mod-BEP
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Germcell/BEP5dayMod.pdf

Mitoxantrone-Prednisolone ver1.2

Description
Chemotherapy Protocol PROSTATE MITOXANTRONE-PREDNISOLONE Regimen  Prostate-Mitoxantrone-Prednisolone Indication  Castrate resistant prostate cancer  Performance status 0, 1, 2  Palliative Toxicity
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Prostatecancer/Mitoxantrone-Prednisolone-ver1.2.pdf

Docetaxel (75)-Prednisolone ver1.2

Description
Chemotherapy Protocol PROSTATE DOCETAXEL(75)-PREDNISOLONE Regimen Prostate-Docetaxel (75)-Prednisolone Indication Advanced castrate resistant prostate cancer Performance status 0, 1
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Prostatecancer/Docetaxel-75-Prednisolone-ver1.2.pdf
431 to 440 of 757
Previous … 42 43 44 45 46 … Next